HomeCompareCINC vs STAG

CINC vs STAG: Dividend Comparison 2026

CINC yields 6.88% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CINC wins by $13.2K in total portfolio value
10 years
CINC
CINC
● Live price
6.88%
Share price
$29.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.5K
Annual income
$1,065.72
Full CINC calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — CINC vs STAG

📍 CINC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCINCSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CINC + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CINC pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CINC
Annual income on $10K today (after 15% tax)
$585.00/yr
After 10yr DRIP, annual income (after tax)
$905.86/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, CINC beats the other by $512.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CINC + STAG for your $10,000?

CINC: 50%STAG: 50%
100% STAG50/50100% CINC
Portfolio after 10yr
$24.9K
Annual income
$763.97/yr
Blended yield
3.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

CINC
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Price Target
$48.50
+66.9% upside vs current
Range: $30.00 — $73.00
Altman Z
75.2
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CINC buys
0
STAG buys
0
No recent congressional trades found for CINC or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCINCSTAG
Forward yield6.88%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$31.5K$18.3K
Annual income after 10y$1,065.72$462.22
Total dividends collected$8.8K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$48.50$45.00

Year-by-year: CINC vs STAG ($10,000, DRIP)

YearCINC PortfolioCINC Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$11,388$688.23$10,665$345.09+$723.00CINC
2$12,918$732.50$11,364$357.70+$1.6KCINC
3$14,599$776.53$12,098$370.43+$2.5KCINC
4$16,441$820.16$12,869$383.28+$3.6KCINC
5$18,455$863.22$13,677$396.23+$4.8KCINC
6$20,652$905.58$14,524$409.27+$6.1KCINC
7$23,045$947.11$15,411$422.41+$7.6KCINC
8$25,646$987.70$16,339$435.61+$9.3KCINC
9$28,468$1,027.26$17,311$448.89+$11.2KCINC
10$31,527$1,065.72$18,327$462.22+$13.2KCINC

CINC vs STAG: Complete Analysis 2026

CINCStock

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Full CINC Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this CINC vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CINC vs SCHDCINC vs JEPICINC vs OCINC vs KOCINC vs MAINCINC vs PLDCINC vs EQRCINC vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.